BR122015020406B8 - uso de compostos de formula i como inibidores de beta-lactamases e composições farmaceuticas - Google Patents

uso de compostos de formula i como inibidores de beta-lactamases e composições farmaceuticas

Info

Publication number
BR122015020406B8
BR122015020406B8 BR122015020406A BR122015020406A BR122015020406B8 BR 122015020406 B8 BR122015020406 B8 BR 122015020406B8 BR 122015020406 A BR122015020406 A BR 122015020406A BR 122015020406 A BR122015020406 A BR 122015020406A BR 122015020406 B8 BR122015020406 B8 BR 122015020406B8
Authority
BR
Brazil
Prior art keywords
compounds
beta
formula
lactamase inhibitors
pharmaceutical compositions
Prior art date
Application number
BR122015020406A
Other languages
English (en)
Other versions
BR122015020406B1 (pt
Inventor
Fromentin Claude
Alan Rowlands David
Aszodi Jozsef
Lampilas Maxime
Original Assignee
Astra Zeneca Holding France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0200951A external-priority patent/FR2835186B1/fr
Application filed by Astra Zeneca Holding France filed Critical Astra Zeneca Holding France
Publication of BR122015020406B1 publication Critical patent/BR122015020406B1/pt
Publication of BR122015020406B8 publication Critical patent/BR122015020406B8/pt

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

compostos heterocíclicos, ativos como inibidores de beta-lactamases. a invenção refere-se ao uso compostos de fórmula (i) e seus sais farmaceuticamente aceitáveis na preparação de um medicamento destinado a inibir a produção de ?-lactamases por bactérias patogênicas.
BR122015020406A 2002-01-28 2003-01-27 uso de compostos de formula i como inibidores de beta-lactamases e composições farmaceuticas BR122015020406B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0200951A FR2835186B1 (fr) 2002-01-28 2002-01-28 Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
BRPI0307267 2003-01-27
PCT/FR2003/000243 WO2003063864A2 (fr) 2002-01-28 2003-01-27 Composes heterocycliques, actifs comme inhibiteurs de beta-lactamases

Publications (2)

Publication Number Publication Date
BR122015020406B1 BR122015020406B1 (pt) 2019-10-29
BR122015020406B8 true BR122015020406B8 (pt) 2021-05-25

Family

ID=68290565

Family Applications (1)

Application Number Title Priority Date Filing Date
BR122015020406A BR122015020406B8 (pt) 2002-01-28 2003-01-27 uso de compostos de formula i como inibidores de beta-lactamases e composições farmaceuticas

Country Status (1)

Country Link
BR (1) BR122015020406B8 (pt)

Also Published As

Publication number Publication date
BR122015020406B1 (pt) 2019-10-29

Similar Documents

Publication Publication Date Title
BRPI0307267B8 (pt) uso de compostos inibidores de beta-lactamases e composições farmacêuticas para terapia antibacteriana
MX2007010072A (es) Derivados de piperidina antibacterianos.
NO20092476L (no) Antibakterielle polycykliske ureaforbindelser
DK1737459T3 (da) Imidazopyridin og imidazopyrimidinderivater som antibakterielle midler
NO20061657L (no) Pyrolderivater med antibakteriell aktivitet
PA8591701A1 (es) Derivados de pirrolopirimidina
BRPI0417458A (pt) compostos inibidores de dpp-iv, sais faramaceuticamente aceitáveis e pró-fármacos do mesmo, seus processos de preparação, composição farmacêutica compreendendo os mesmos e uso dos referidos compostos na fabricação de medicamento
GEP20125487B (en) Organic compounds and their use
TW200722081A (en) New therapeutic combinations for the treatment or prevention of depression
CR11482A (es) Derivados de 1,2,3-triazol para uso como inhibidores de estearoil-coenzima a desaturasa
NO20083250L (no) Antibakterielle pyrrolopyridiner, pyrrolopyrimidiner og pyrroloazepiner
BRPI0408437A (pt) derivados de p-diaminobenzeno substituìdos, composição farmacêutica, e, uso da mesma
MX2010013310A (es) Derivados de heterociclil urea para el tratamiento de infecciones bacterianas.
MY140630A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0301701D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
BRPI0409882A (pt) compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
SE0301699D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
MX2008012093A (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de trastornos psicoticos.
BRPI0409878A (pt) compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
BR0318659A (pt) derivados de prolina usados como ingredientes farmacêuticos ativos no tratamento de tumores
SE0102057D0 (sv) New Salts I
BR122015020406B8 (pt) uso de compostos de formula i como inibidores de beta-lactamases e composições farmaceuticas
TW200626567A (en) Benzoxazine and quinoxaline derivatives and uses
TW200736270A (en) Macrolones
TW200626582A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/10/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/10/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/01/2003 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B25G Requested change of headquarter approved

Owner name: ASTRA ZENECA HOLDING FRANCE (FR)

B25A Requested transfer of rights approved

Owner name: PFIZER IRELAND PHARMACEUTICALS (IE)

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 27/01/2023